{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:08:50Z","timestamp":1793362130475,"version":"4.5.0"},"reference-count":65,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2009,2,13]],"date-time":"2009-02-13T00:00:00Z","timestamp":1234483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anaesthesia"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>The pharmacodynamics and pharmacokinetics of the currently available neuromuscular blocking and reversal drugs may be altered by organ disease. Adverse effects such as prolonged neuromuscular block, postoperative residual curarisation, recurarisation, the muscarinic effects of the anticholinesterases, and the side\u2010effects of the antimuscarinics are encountered more frequently. This review will consider these potential problems and assess the role of sugammadex in enabling the anaesthetist to avoid them. It will also present the latest knowledge regarding the safety and efficacy of sugammadex in patients with renal, hepatic, cardiovascular and pulmonary disease.<\/jats:p>","DOI":"10.1111\/j.1365-2044.2008.05871.x","type":"journal-article","created":{"date-parts":[[2009,2,13]],"date-time":"2009-02-13T10:18:28Z","timestamp":1234520308000},"page":"55-65","source":"Crossref","is-referenced-by-count":57,"title":["Neuromuscular blocking drugs and their antagonists in patients with organ disease"],"prefix":"10.1111","volume":"64","author":[{"given":"R. G.","family":"Craig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,2,13]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/68.5.492"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/73.5.613"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/49.9.945"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1978.tb01313.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/0310057X9001800114"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-200007000-00044"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03010829"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/59.8.995"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/54.5.513"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199406000-00011"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03026928"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt19772211"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198109000-00015"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-199502000-00029"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/64.2.186"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/56.9.941"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/48.3.253"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/67.5.569"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198412000-00011"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/62.2.177"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/57.2.160"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/75.4.431"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/74.4.400"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/76.5.624"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/59.2.218"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/59.6.697"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/75.1.31"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/50.11.1131"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/48.4.341"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00561401"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-197605000-00012"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1987.tb05252.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/47.11.1199"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-198603000-00005"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198808000-00012"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1987.tb03980.x"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198805000-00016"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/57.8.758"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198505000-00010"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03007578"},{"key":"e_1_2_6_42_2","first-page":"133","article-title":"Safety aspects of non\u2010depolarizing neuromuscular blocking agents with special reference to rocuronium bromide","volume":"9","author":"Mirakhur RK","year":"1994","journal-title":"European Journal of Anaesthesiology Supplement"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003643-200501000-00002"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/71.2.222"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-199504000-00018"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199605000-00011"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1997.00653.x"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1991.tb09609.x"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-197909000-00008"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/53.12.1311"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0000244594.63318.fc"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200510000-00007"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.anes.0000265152.78943.74"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aen037"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0000248224.42707.48"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0000260135.46070.c3"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e31817f5bc7"},{"key":"e_1_2_6_58_2","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0000250617.79166.7f"},{"key":"e_1_2_6_59_2","first-page":"A1158","article-title":"Rapid reversal of rocuronium\u2010induced neuromuscular blockade by Org 25969 is independent of renal function","volume":"99","author":"Bom A","year":"2003","journal-title":"Anesthesiology"},{"key":"e_1_2_6_60_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aen216"},{"key":"e_1_2_6_61_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200604000-00009"},{"key":"e_1_2_6_62_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aem402"},{"key":"e_1_2_6_63_2","first-page":"A1581","article-title":"Reversal of rocuronium\u2010induced neuromuscular blockade by sugammadex in cardiac patients","volume":"107","author":"Dahl V","year":"2007","journal-title":"Anesthesiology"},{"key":"e_1_2_6_64_2","first-page":"A1580","article-title":"Single IV sugammadex doses up to 32\u2003mg\/kg are not associated with Qt\/QTc prolongation","volume":"107","author":"De Kam P","year":"2007","journal-title":"Anesthesiology"},{"key":"e_1_2_6_65_2","first-page":"9AP5","article-title":"Single IV sugammadex doses up to 32\u2003mg\/kg alone or in combination with rocuronium or vecuronium are not associated with QTc prolongation","volume":"25","author":"De Kam P","year":"2008","journal-title":"European Journal of Anaesthesiology"},{"key":"e_1_2_6_66_2","first-page":"A1582","article-title":"Sugammadex safely reverses rocuronium\u2010induced blockade in patients with pulmonary disease","volume":"107","author":"Amao R","year":"2007","journal-title":"Anesthesiology"}],"container-title":["Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2044.2008.05871.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/associationofanaesthetists-publications.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2044.2008.05871.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T22:03:56Z","timestamp":1761689036000},"score":1,"resource":{"primary":{"URL":"https:\/\/associationofanaesthetists-publications.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2044.2008.05871.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,13]]},"references-count":65,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1111\/j.1365-2044.2008.05871.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2044.2008.05871.x","archive":["Portico"],"relation":{},"ISSN":["0003-2409","1365-2044"],"issn-type":[{"value":"0003-2409","type":"print"},{"value":"1365-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,13]]}}}